BioXcel Therapeutics to Present at Two Upcoming Investor Conferences

BioXcel Therapeutics to Present at Two Upcoming Investor Conferences

NEW HAVEN, Conn., Nov. 14, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company using artificial intelligence approaches to develop transformative drugs in neuroscience and immuno-oncology, has announced today that Vimal Mehta, Ph.D., Founder and CEO, and Matt Wiley, Chief Commercial Officer, will participate in fireside chats at two upcoming investor conferences. …

BioXcel Therapeutics to Present at Two Upcoming Investor Conferences Read More »